Nieuws en video's - HYTN INNOVATIONS MMOED - Engels

U bekijkt momenteel alle beurs nieuws van het financieel instrument HYTN INNOVATIONS MMOED over alle markten in Engels.

HYTN INNOVATIONS MMOED > Nieuws GlobeNewsWire heeft een nieuws gepubliceerd.

HYTN Announces Sale and Distribution of GMP Cannabis Products in the UK • • GlobeNewsWire • Aandelen

VANCOUVER, British Columbia, Dec. 16, 2024 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) ("HYTN" or "the Company"), a pharmaceutical company specializing in the development, formulation, and manufacturing of psychoactive and psychotropic compounds, including cannabis and psilocybin, is pleased to announce its successful export of cannabis to the United Kingdom’s 4C LABS. This announcement follows the news from November 28, 2024, that the Company received its...

Dank u

HYTN INNOVATIONS MMOED > Nieuws GlobeNewsWire heeft een nieuws gepubliceerd.

HYTN Receives Opening Order and Import Permits from the UK's 4C Labs, Prepares Products for Export • • GlobeNewsWire • Aandelen

VANCOUVER, British Columbia, Nov. 28, 2024 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) (“HYTN” or “the Company”), a pharmaceutical company specializing in the development, formulation, and manufacturing of psychoactive and psychotropic compounds, including cannabis and psilocybin, is pleased to announce the receipt of initial orders and import permits from the UK's 4C Labs, marking a significant milestone in their partnership. This achievement allows...

Dank u

HYTN INNOVATIONS MMOED > Nieuws GlobeNewsWire heeft een nieuws gepubliceerd.

HYTN Announces Marketing Program • • GlobeNewsWire • Aandelen

VANCOUVER, British Columbia, Nov. 08, 2024 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) (“HYTN” or “the Company”), a company specializing in the pharmaceutical development and production of psychoactive and psychotropic compounds, including cannabis and psilocybin, is pleased to announce that it has engaged bullVestor Medien GmbH (“bullVestor”) (address: Gutenhofen 4, 4300, St. Valentin, Austria email: [email protected] ) to provide marketing...

Dank u

HYTN INNOVATIONS MMOED > Nieuws GlobeNewsWire heeft een nieuws gepubliceerd.

HYTN Expands GMP Capabilities with New Licensed Activity • • GlobeNewsWire • Aandelen

VANCOUVER, British Columbia, Oct. 09, 2024 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN , FSE: 85W0 , OTC PINK: HYTNF ) (“ HYTN ” or “the Company ”), a pharmaceutical company specializing in the development, formulation, and manufacturing of psychoactive and psychotropic compounds, including cannabis and psilocybin, proudly announces that it has received an additional Good Manufacturing Practices (“GMP”) certification for its Kelowna manufacturing facility. This certification...

Dank u

HYTN INNOVATIONS MMOED > Nieuws GlobeNewsWire heeft een nieuws gepubliceerd.

HYTN Files Business Acquisition Report • • GlobeNewsWire • Aandelen

VANCOUVER, British Columbia, Sept. 27, 2024 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) (“HYTN” or “the Company”), a pharmaceutical company specializing in the development, formulation, and manufacturing of psychoactive and psychotropic compounds, including cannabinoids and psilocybin, is pleased to announce, further to its news release dated July 19, 2024, that it has filed a Business Acquisition Report (BAR) in respect of its acquisition of Prism...

Dank u

HYTN INNOVATIONS MMOED > Nieuws GlobeNewsWire heeft een nieuws gepubliceerd.

HYTN Partners with the UK's 4C Labs, Validates GMP Certification • • GlobeNewsWire • Aandelen

VANCOUVER, British Columbia, Sept. 10, 2024 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) (“HYTN” or “the Company”), a pharmaceutical company specializing in the development, formulation, and manufacturing of psychoactive and psychotropic compounds, including cannabinoids and psilocybin, is proud to announce the establishment of international manufacturing and pricing agreements (the Agreements) with 4C LABS, a leading importer and distributor of...

Dank u

HYTN INNOVATIONS MMOED > Nieuws GlobeNewsWire heeft een nieuws gepubliceerd.

HYTN Lists on the OTC Pink Market • • GlobeNewsWire • Aandelen

VANCOUVER, British Columbia, July 29, 2024 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN | FSE: 85W0 | OTC PINK: HYTNF) “HYTN” or “the Company”, a pharmaceutical company specializing in the development, formulation, and manufacturing of products containing psychoactive and psychotropic compounds, including cannabis and psilocybin, is pleased to announce its approval for trading on the OTC PINK Market ("OTC PINK") effective July 29th, 2024, under the trading symbol “HYTNF”....

Dank u

HYTN INNOVATIONS MMOED > Nieuws GlobeNewsWire heeft een nieuws gepubliceerd.

HYTN Completes Acquisition of Prism Scientific Labs, Enhancing Psychedelic Compound Manufacturing Capabilities • • GlobeNewsWire • Aandelen

VANCOUVER, British Columbia, July 19, 2024 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN | FSE: 85W0) "HYTN" or "The Company", a leader in the development, formulation, and manufacturing of psychoactive and psychotropic compounds, including cannabis and psilocybin, is pleased to announce, further to its news release dated June 13, 2024, the completion of its acquisition (“ Acquisition ”) of all of the issued and outstanding share capital of Prism Scientific Labs Inc. (Prism), a...

Dank u

HYTN INNOVATIONS MMOED > Nieuws GlobeNewsWire heeft een nieuws gepubliceerd.

HYTN Awarded Drug Establishment License from Health Canada, Expanding GMP Capabilities • • GlobeNewsWire • Aandelen

VANCOUVER, British Columbia, June 27, 2024 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN | FSE: 85W0) “HYTN” or “The Company”, a leader in the development, formulation, and manufacturing of products containing psychoactive and psychotropic compounds, including cannabis and psilocybin, is pleased to announce that it has been granted a Drug Establishment License (DEL) by Health Canada. This license allows HYTN to engage in the GMP fabrication, packaging, and labeling of non-sterile...

Dank u

HYTN INNOVATIONS MMOED > Nieuws GlobeNewsWire heeft een nieuws gepubliceerd.

HYTN Welcomes U.S. Recommendation to Reclassify Cannabis, Foresees Growth • • GlobeNewsWire • Aandelen

VANCOUVER, British Columbia, May 01, 2024 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN “HYTN” or “The Company”), a leader in the development, formulation, and manufacturing of products containing psychoactive and psychotropic compounds including cannabis, applauds the recent formal recommendation by the U.S. Justice Department, endorsed by the Drug Enforcement Agency (DEA), to reclassify cannabis from a Schedule I to a Schedule III controlled substance. This historic shift,...

Dank u

HYTN INNOVATIONS MMOED > Nieuws GlobeNewsWire heeft een nieuws gepubliceerd.

HYTN Innovates GMP Stability Programs, Sets Industry Benchmark • • GlobeNewsWire • Aandelen

VANCOUVER, British Columbia, April 22, 2024 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN | FSE: 85W0) “HYTN” or “The Company”, a leader in the development, formulation, and manufacturing of products containing psychoactive and psychotropic compounds, including cannabis, is pleased to announce significant advancements in its Good Manufacturing Practice (GMP) stability programs. Stability programs constitute a cornerstone of all GMP guidelines and are vital for achieving GMP...

Dank u

HYTN INNOVATIONS MMOED > Nieuws GlobeNewsWire heeft een nieuws gepubliceerd.

HYTN Welcomes Health Canada for Audit to Enhance GMP Capabilities • • GlobeNewsWire • Aandelen

VANCOUVER, British Columbia, April 09, 2024 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, “HYTN” or “The Company”), a leader in the development, formulation, and manufacturing of products containing psychoactive and psychotropic compounds, including cannabis, welcomed Health Canada’s conduct of a Drug Establishment License (DEL) audit. The audit, which aims to expand the Company's Good Manufacturing Practices (GMP) capabilities, follows the recent achievement of GMP...

Dank u

HYTN INNOVATIONS MMOED > Nieuws GlobeNewsWire heeft een nieuws gepubliceerd.

HYTN Provides Corporate Update, Outlines New Global Direction • • GlobeNewsWire • Aandelen

VANCOUVER, British Columbia, April 03, 2024 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN | FSE: 85W0, "HYTN" or "The Company"), a leader in the development, formulation, and manufacturing of products containing psychoactive and psychotropic compounds, including cannabis, is pleased to provide an update on the company’s new strategic goals and plans for global commercialization. This follows the recent achievement of Good Manufacturing Practices (GMP) certification for HYTN's Kelowna...

Dank u

HYTN INNOVATIONS MMOED > Nieuws GlobeNewsWire heeft een nieuws gepubliceerd.

HYTN Secures GMP Certification • • GlobeNewsWire • Aandelen

VANCOUVER, British Columbia, March 21, 2024 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN "HYTN or The Company"), a Canadian company at the forefront of developing, formulating, and manufacturing products with psychoactive and psychotropic compounds, including those from cannabis and psilocybin, has been awarded Good Manufacturing Practice (GMP) certification by Australia's Therapeutic Goods Administration (TGA) for its Kelowna production facility. This announcement supplements the...

Dank u

HYTN INNOVATIONS MMOED > Nieuws GlobeNewsWire heeft een nieuws gepubliceerd.

HYTN Clears PIC/S GMP Audit, Primed for Global Expansion • • GlobeNewsWire • Aandelen

VANCOUVER, British Columbia, March 04, 2024 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN | FSE: 85W0) (the “ Company ” or “ HYTN ”), a company at the forefront of developing, formulating, and manufacturing products with psychoactive and psychotropic compounds, including those from cannabis and psilocybin, proudly announces the successful completion of a Good Manufacturing Practices (“ GMP ”) audit by Australia's Therapeutic Goods Administration (“ TGA ”) at their Kelowna...

Dank u

HYTN INNOVATIONS MMOED > Nieuws GlobeNewsWire heeft een nieuws gepubliceerd.

HYTN Broadens Reach with Innovative Cannabis-Infused Nano Shot • • GlobeNewsWire • Aandelen

VANCOUVER, British Columbia, Feb. 20, 2024 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN " HYTN or The Company "), a leader in the cannabis sector known for specialized psychoactive and psychotropic product development, is excited to announce the expansion of its 100 mg Nano Shot Citrus (“ Nano Shot ”) to the key markets of British Columbia and Alberta. Following its initial success in Ontario, Canada's largest market, this move represents a significant stride in the company's...

Dank u

HYTN INNOVATIONS MMOED > Nieuws GlobeNewsWire heeft een nieuws gepubliceerd.

HYTN Announces Non-Brokered Private Placement for up to C$1 Million • • GlobeNewsWire • Aandelen

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Feb. 09, 2024 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (the “ Company ” or “ HYTN ”) (CSE: HYTN) is pleased to announce a non-brokered private placement of up to 13,333,334 units of the Company (“ Units ”) at a price of $0.075 per Unit (the “ Offering ”), for aggregate gross proceeds of up to $1,000,000.05. Each Unit will be composed of one (1) common...

Dank u

HYTN INNOVATIONS MMOED > Nieuws GlobeNewsWire heeft een nieuws gepubliceerd.

HYTN Announces Closing of Non-Brokered Private Placement Under Listed Issuer Financing Exemption • • GlobeNewsWire • Aandelen

VANCOUVER, British Columbia, Oct. 26, 2023 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (the “ Company ” or “ HYTN ”) (CSE: HYTN) is pleased to announce that it has closed its previously announced non-brokered private placement of units of the Company (“ Units ”) by issuing a total of 5,050,000 Units at a price of $0.10 per Unit (the “ Offering ”) for aggregate gross proceeds of $505,000. Each Unit consists of one (1) common share in the capital of the Company (a “ Share ”) and...

Dank u

HYTN INNOVATIONS MMOED > Nieuws GlobeNewsWire heeft een nieuws gepubliceerd.

HYTN Innovations expands its Controlled Drugs and Substances Dealers License to include MDMA and Ketamine • • GlobeNewsWire • Aandelen

VANCOUVER, British Columbia, March 02, 2023 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (“ HYTN ” or the “ Company ”) (CSE: HYTN), a Vancouver-based company specializing in the production of psychoactive and psychotropic compounds, announced today that it has submitted an amendment to its Controlled Drugs and Substances Dealers License with Health Canada. The amendment, if approved, will allow the company to expand its work to include additional compounds such as MDMA, ketamine, LSD,...

Dank u

HYTN INNOVATIONS MMOED > Nieuws GlobeNewsWire heeft een nieuws gepubliceerd.

HYTN Innovations Cultivates Psilocybin Mushrooms and Upgrades Equipment for API Development • • GlobeNewsWire • Aandelen

VANCOUVER, British Columbia, Feb. 23, 2023 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (“ HYTN ” or the “ Company ”) (CSE: HYTN) announced that it has successfully initiated cultivation of psilocybin mushrooms under its Dealer’s License granted by Health Canada in accordance with the Controlled Drugs and Substances Act. This announcement is a significant development supporting HYTN's mission to be a leading manufacturer of psychoactive and psychotropic compounds. The company also...

Dank u